American Well CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
American Well Corporation reported a 18% revenue decrease in Q1 2026 compared to the prior year, driven by lower subscription and other revenues, alongside significant cost-cutting measures.
NYSE
Amwell reported a significant reduction in net loss and improved Adjusted EBITDA for Q3 and the first nine months of 2025, driven by strategic cost-cutting and increased subscription revenue.
NYSE
Amwell reported significantly reduced net losses and strong subscription revenue growth in Q2 2025, driven by strategic divestitures and cost-cutting measures.
NYSE
American Well Corporation (Amwell) announces its Q1 2025 financial results, highlighting a 12% increase in revenue and strategic adjustments including the divestiture of Aligned Telehealth.
NYSE
American Well Corporation's third quarter 2024 results show a slight revenue decrease and a net loss, as the company continues its strategic transformation and platform migration.
NYSE
American Well Corporation's Q2 2024 results show flat revenue year-over-year as the company continues its platform transition.
NYSE
American Well Corporation's first quarter 2024 results show a decrease in revenue and a net loss, impacted by customer churn during platform migration and increased investment in government sector products.